Sanofi receives CHMP recommendation for Dupixent expansion in Europe
The CHMP’s recommendation is based on LIBERTY-CUPID data, including two Phase III and the CUPIDKids studies.
Drug Development
BioMarin receives FDA approval for Palynziq use in adolescents
Quotient and Ipsen extend partnership for ultra-rare disease therapy
IQVIA to acquire Charles River drug discovery assets
Novo Nordisk and Vivtex collaborate for oral medicines development
Slate Medicines raises $130m in funds to progress anti-PACAP treatments
NorthX Biologics and Demeetra collaborate on GMP manufacturing and CLD
FDA accepts Beren Therapeutics’ NDA for Niemann-Pick disease
